The abstract is read at the publisher; the summary is JClub's.
Subretinal AAV gene replacement of codon-optimized human KCNV2 in Kv8.2 knockout mice significantly restores retinal function, with improved ERG responses and corrected KCNV2/Kv8.2 expression.
- Why it matters: KCNV2 retinopathy from Kv8.2 dysfunction is currently incurable and causes lifelong visual loss with abnormal ERG responses, creating a need for therapeutic strategies that restore retinal physiology.
- What they did: The study delivered an AAV vector subretinally into Kv8.2 knockout mice and assessed ERG and optomotor reflex recovery, then tested KCNV2 rescue in human retinal organoids from a patient-derived iPSC line.
- The result: Treated mice showed visually guided scotopic and photopic optomotor reflex responses reaching wild-type levels even at lower vector doses, and patient-derived organoids exhibited substantial Kv8.2 protein rescue.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.